Latest Insider Transactions at Repligen Corp (RGEN)
This section provides a real-time view of insider transactions for Repligen Corp (RGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REPLIGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REPLIGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
686
+23.0%
|
-
|
|
May 18
2023
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
686
+22.63%
|
-
|
|
May 18
2023
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
686
+24.04%
|
-
|
|
May 18
2023
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
798
+1.02%
|
-
|
|
May 18
2023
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
686
+8.3%
|
-
|
|
May 18
2023
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
686
+19.87%
|
-
|
|
May 18
2023
|
Konstantin Konstantinov |
BUY
Grant, award, or other acquisition
|
Direct |
686
+35.99%
|
-
|
|
May 16
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-1.86%
|
$109,340
$154.03 P/Share
|
|
May 16
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.01%
|
$51,436
$154.03 P/Share
|
|
May 16
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-2.93%
|
$109,340
$154.03 P/Share
|
|
May 08
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+23.69%
|
$78,000
$156.18 P/Share
|
|
May 05
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+31.04%
|
$79,500
$159.19 P/Share
|
|
May 04
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+45.0%
|
$80,500
$161.15 P/Share
|
|
Apr 04
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.87%
|
$54,442
$163.45 P/Share
|
|
Mar 24
2023
|
Martin D Madaus |
BUY
Small Acquisition
|
Indirect |
11
+50.0%
|
$2,046
$186.22 P/Share
|
|
Mar 03
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,247
-4.89%
|
$234,436
$188.0 P/Share
|
|
Mar 03
2023
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,591
+12.34%
|
-
|
|
Mar 03
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,674
-8.8%
|
$690,712
$188.0 P/Share
|
|
Mar 03
2023
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,795
+17.4%
|
-
|
|
Mar 03
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-0.38%
|
$23,688
$188.0 P/Share
|
|
Mar 03
2023
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
375
+1.12%
|
-
|
|
Mar 03
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
8,244
-4.05%
|
$1,549,872
$188.0 P/Share
|
|
Mar 03
2023
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
18,584
+8.37%
|
-
|
|
Mar 03
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
210
-1.16%
|
$39,480
$188.0 P/Share
|
|
Mar 03
2023
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
625
+3.34%
|
-
|
|
Mar 02
2023
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,468
+13.66%
|
-
|
|
Mar 02
2023
|
Jon Snodgres Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,848
+12.82%
|
-
|
|
Mar 02
2023
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
3,467
+9.6%
|
-
|
|
Mar 02
2023
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
19,393
+9.49%
|
-
|
|
Mar 02
2023
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,348
+32.31%
|
-
|
|
Mar 02
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
6,670
-3.87%
|
$1,173,920
$176.37 P/Share
|
|
Mar 02
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
630
-2.11%
|
$109,620
$174.37 P/Share
|
|
Feb 28
2023
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
6,021
-1.7%
|
$1,041,633
$173.36 P/Share
|
|
Feb 28
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
912
-1.49%
|
$157,776
$173.36 P/Share
|
|
Feb 28
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
816
-2.14%
|
$141,168
$173.36 P/Share
|
|
Feb 28
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,203
-2.07%
|
$208,119
$173.36 P/Share
|
|
Feb 28
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
594
-6.1%
|
$102,762
$173.44 P/Share
|
|
Feb 16
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,647
-16.15%
|
$1,129,400
$200.0 P/Share
|
|
Feb 06
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
111
+50.0%
|
-
|
|
Nov 11
2022
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
25,000
-12.3%
|
$5,000,000
$200.0 P/Share
|
|
Nov 11
2022
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+10.95%
|
$825,000
$33.87 P/Share
|
|
Oct 07
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
466
+1.32%
|
$27,494
$59.52 P/Share
|
|
Sep 09
2022
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
775
-1.0%
|
$175,925
$227.17 P/Share
|
|
Sep 08
2022
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
26,402
-1.7%
|
$5,887,646
$223.76 P/Share
|
|
Sep 08
2022
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.66%
|
$330,000
$33.87 P/Share
|
|
Aug 16
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,698
-8.47%
|
$1,687,896
$252.93 P/Share
|
|
Aug 16
2022
|
Jon Snodgres Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,017
+4.67%
|
$602,550
$150.84 P/Share
|
|
Aug 11
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
4,840
-10.32%
|
$1,229,360
$254.67 P/Share
|
|
Aug 11
2022
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+5.45%
|
$236,000
$59.56 P/Share
|
|
Aug 04
2022
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
3,357
-9.85%
|
$815,751
$243.01 P/Share
|